Skip to content

Net Income at other companies

Medtronic logo
MedtronicMDT
$1.26B+18.7%
LivaNova logo
LivaNovaLIVN
$22.29M+107%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$9.55M-58.5%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
-$11.29M-477%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$20.91M+60.6%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
-$60.62M-78.6%

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Gross profit$18.0M+4.1%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Gross margin78.3%+3.5pp
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s net income?
Neuropace, Inc. (NPCE) reported net income of -$6.69M in Q1 2026.
How has Neuropace, Inc.'s net income changed year-over-year?
Neuropace, Inc.'s net income decreased by 1.5% year-over-year, from -$6.59M to -$6.69M.
What is the long-term trend for Neuropace, Inc.'s net income?
Over 4 years (2021 to 2025), Neuropace, Inc.'s net income has grown at a -12.2% compound annual growth rate (CAGR), from -$36.08M to -$21.47M.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.